The growing recognition of the impact of breast density

With an estimated 562,500 new cases per year, breast cancer remains the most common cancer impacting women across Europe [1]. National breast screening programs for
women of average risk are offered in nearly all European countries based on the European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis and The European Society of Breast Imaging (EUSOBI) attributes a 40% reduction in breast cancer mortality to population-based screening [2].


Read More

Breast Imaging Density screening ABUS2 Schultz GE